Treatment of Patients with Atrial FibrillationByMohammad J. Tafreshi, PharmD, BCPS,Kim N. Hoang, PharmD,Melinda L. Adkins, PharmDDecember 1st 2004
Cardiovascular Update: The Role of Combination ACE Inhibitors and Angiotensin II Receptor BlockersByKelley Chiaventone, PharmD,Narith Ou, PharmD, BCPSDecember 1st 2004
Understanding and Managing Polypharmacy in the ElderlyByYvette C. Terrie, BSPharm, RPhDecember 1st 2004
Effective Counseling for Patients with HypertensionByGuido R. Zanni, PhD,Jeannette Yeznach Wick, RPh, MBADecember 1st 2004
RxPRODUCT NEWS: PROFILE: Cardizem LA (diltiazem hydrochloride)ByMonica Holmberg, PharmDDecember 1st 2004
Drug Interactions and QT Interval ProlongationByJohn R. Horn, PharmD, FCCP,Philip D. Hansten, PharmDDecember 1st 2004